BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27069297)

  • 1. Diagnosis and Prognostic Significance of c-Met in Cervical Cancer: A Meta-Analysis.
    Peng J; Qi S; Wang P; Li W; Liu C; Li F
    Dis Markers; 2016; 2016():6594016. PubMed ID: 27069297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer.
    Kim HS; Yoon G; Ryu JY; Cho YJ; Choi JJ; Lee YY; Kim TJ; Choi CH; Song SY; Kim BG; Bae DS; Lee JW
    Oncotarget; 2015 Sep; 6(29):26746-56. PubMed ID: 26311741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological and prognostic significance of Bmi-1 expression in human cervical cancer.
    Min L; Dong-Xiang S; Xiao-Tong G; Ting G; Xiao-Dong C
    Acta Obstet Gynecol Scand; 2011 Jul; 90(7):737-45. PubMed ID: 21309753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of downregulated E-cadherin as a poor prognostic biomarker for cervical cancer.
    Peng J; Qi S; Wang P; Li W; Song L; Liu C; Li F
    Future Oncol; 2016 Mar; 12(5):715-26. PubMed ID: 26653706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High c-Met expression is a negative prognostic marker for colorectal cancer: a meta-analysis.
    Gao H; Guan M; Sun Z; Bai C
    Tumour Biol; 2015 Feb; 36(2):515-20. PubMed ID: 25636446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and prognostic value of STAT3/p-STAT3 in cervical cancer: A meta and bioinformatics analysis.
    Shi S; Ma HY; Zhang ZG
    Pathol Res Pract; 2021 Nov; 227():153624. PubMed ID: 34571355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of miRNA-21 and their potential as biomarkers for the diagnosis of cervical cancer.
    Han Y; Xu GX; Lu H; Yu DH; Ren Y; Wang L; Huang XH; Hou WJ; Wei ZH; Chen YP; Cao YG; Zhang R
    Int J Clin Exp Pathol; 2015; 8(6):7131-9. PubMed ID: 26261606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer.
    Hazelbag S; Kenter GG; Gorter A; Fleuren GJ
    Int J Cancer; 2004 Dec; 112(6):1020-8. PubMed ID: 15386352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
    Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
    Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.
    Jin Y; Sun PL; Kim H; Seo AN; Jheon S; Lee CT; Chung JH
    Ann Surg Oncol; 2014 Feb; 21(2):621-8. PubMed ID: 24212721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt5A expression is associated with the tumor metastasis and clinical survival in cervical cancer.
    Lin L; Liu Y; Zhao W; Sun B; Chen Q
    Int J Clin Exp Pathol; 2014; 7(9):6072-8. PubMed ID: 25337253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lgr5 is a potential prognostic marker in patients with cervical carcinoma.
    Sun B; Ye X; Li Y; Zhang W
    Int J Clin Exp Pathol; 2015; 8(2):1783-9. PubMed ID: 25973068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-Met as a prognostic marker in gastric cancer: a systematic review and meta-analysis.
    Yu S; Yu Y; Zhao N; Cui J; Li W; Liu T
    PLoS One; 2013; 8(11):e79137. PubMed ID: 24223894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of c-Met in colorectal cancer: a meta-analysis.
    Liu Y; Yu XF; Zou J; Luo ZH
    World J Gastroenterol; 2015 Mar; 21(12):3706-10. PubMed ID: 25834339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of microRNA-126 is associated with poor prognosis in patients with cervical cancer.
    Yang Y; Song KL; Chang H; Chen L
    Diagn Pathol; 2014 Dec; 9():220. PubMed ID: 25551621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent hepatocyte growth factor overexpression and low frequency of c-Met gene amplification in human papillomavirus-negative tonsillar squamous cell carcinoma and their prognostic significances.
    Kwon MJ; Kim DH; Park HR; Shin HS; Kwon JH; Lee DJ; Kim JH; Cho SJ; Nam ES
    Hum Pathol; 2014 Jul; 45(7):1327-38. PubMed ID: 24810547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-MET immunostaining in colorectal carcinoma is associated with local disease recurrence.
    Al-Maghrabi J; Emam E; Gomaa W; Saggaf M; Buhmeida A; Al-Qahtani M; Al-Ahwal M
    BMC Cancer; 2015 Oct; 15():676. PubMed ID: 26459369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The expression of c-myc protein in uterine cervical cancer: a possible prognostic indicator].
    Wu HJ
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Jul; 48(7):515-21. PubMed ID: 8754393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.